Three Drug Classes: Antibiotics, Analgesics, and Local Anesthetics Mod I: Antibiotics, 3rd Edition

After completing this course, the participant will be able to discuss the differences among antibiotics typically prescribed for orofacial infections. In the case of special patient populations such as orthopedic, cardiac, and immunosuppressed individuals, the selection and timing of appropriate prophylactic antibiotics will be made clear. The principles learned will also be directly applicable to the appropriate selection of antimicrobial therapy for the pregnant or breastfeeding patient and will aid in recognizing those patients with a significant allergic history and how to best and safely treat them. This intermediate-level course is specifically designed for all members of the dental healthcare team: dentists, dental hygienists, and dental assistants.

 

Course Objectives:

Mark Donaldson, BSP, RPH, PharmD, FASHP, FACHE, received his baccalaureate degree from the University of British Columbia (UBC) and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and is the current Associate Principal for Vizient Pharmacy Advisory Solutions. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula and clinical associate professor in both the School of Dentistry at the Oregon Health & Science University in Portland, Oregon, and the Faculty of Dentistry at UBC in Vancouver. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored several textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization. He currently serves on the Editorial Board for the Journal of the American Dental Association, is board certified in healthcare management, and is the past-president and past-Regent of the American College of Healthcare Executives’ Montana Chapter.

Disclosures
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.

Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.

 

Colibri Healthcare, LLC is designated as a Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. Current approval period is 1/1/2022 to 12/31/2025; Provider ID# 217536.